OverviewSuggest Edit

Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and our 11,000 employees manufacture our products in local markets, close to our customers. With over 40 plants in Europe, North America, South America and Asia, we generate revenues of more than EUR 1.4 billion. Our comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
TypePublic
Founded1864
HQDüsseldorf, DE
Websitegerresheimer.com
Employee Ratings3

Latest Updates

Employees (est.) (Jul 2021)9,904
Job Openings202
Share Price (Oct 2021)€80.6
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Gerresheimer

Dietmar Siemssen

Dietmar Siemssen

CEO
Rainer Beaujean

Rainer Beaujean

CFO
Lukas Burkhardt

Lukas Burkhardt

Primary Packaging Glass Division
Andreas Schutte

Andreas Schutte

Plastics & Devices and Advanced Technologies Divisions
Axel Herberg

Axel Herberg

Chairman of the Supervisory Board
Francesco Grioli

Francesco Grioli

Deputy Chairman of the Supervisory Board
Show more

Gerresheimer Office Locations

Gerresheimer has offices in Düsseldorf, Bünde, Essen, Pfreimd and in 19 other locations
Düsseldorf, DE (HQ)
Klaus-Bungert-Straße 4
Bünde, DE
Erich-Martens-Straße 26-32
Essen, DE
Ruhrau 50
Pfreimd, DE
Gewerbegebiet An der Ringstraße, Hirtenstraße 50
Regensburg, DE
Kumpfmühler Str. 2
Tettau, DE
Tettaugrundstraße 1
Show all (26)

Gerresheimer Financials and Metrics

Gerresheimer Revenue

Market capitalization (15-Oct-2021)

2.6b

Closing stock price (15-Oct-2021)

80.6
Gerresheimer's current market capitalization is €2.6 b.
Show all financial metrics

Gerresheimer Cybersecurity Score

Cybersecurity ratingPremium dataset

C

76/100

SecurityScorecard logo

Gerresheimer Online and Social Media Presence

Embed Graph

Gerresheimer News and Updates

Gerresheimer accelerates revenue growth

Organic Group revenue growth of 7.5 %, and 7.1 % in core business Solutions for biotech drugs and high-value solutions continue to drive revenues increase Organic adjusted EBITDA margin at 22.8 % in core business Adjusted earnings per share up organically by 19.1 % to EUR 1.28 Guidance...

Worldwide Smart Syringe Industry to 2027 - Featuring Gerresheimer, Sharps Technology and Retractable Technologies Among Others

Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Smart Syringe Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering. Smart syringes can be classified in three categories, auto-disabled syringes (widely used for vaccination d…

Insights on the Injectable Packaging and Component Global Market to 2025 - Featuring West Pharmaceuticals, Gerresheimer, Ypsomed and Datwyler Holding Among Others

Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Global Injectable Packaging and Component Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's offering.

Global Dropper Market (2021 to 2025) - Featuring Adelphi Healthcare Packaging, Comar and Gerresheimer Among Others

Dublin, April 06, 2021 (GLOBE NEWSWIRE) -- The "Global Dropper Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Patient Controlled Injectors Market to sale $ 7,505.70 million by 2027 | Ypsomed AG, Enable Injections, scPharmaceuticals, Gerresheimer AG

The patient controlled market was valued at US$ 2,969.47 million in 2019 and is projected to reach US$ 7,505.70 million by 2027; it is expected to grow at a CAGR of 12.4% from 2020 to 2027. Posted via Industry Today. Follow us on Twitter @IndustryToday

Gerresheimer on track for strong second half-year

DUSSELDORF, Germany, Oct. 13, 2020 /PRNewswire/ -- Gerresheimer AG delivered profitable growth in its core business in the third quarter of 2020 and confirmed its guidance for 2020 despite temporarily lower demand for high-quality perfume flacons due to Covid-19. "We are working together...
Show more

Gerresheimer Frequently Asked Questions

  • When was Gerresheimer founded?

    Gerresheimer was founded in 1864.

  • Who are Gerresheimer key executives?

    Gerresheimer's key executives are Dietmar Siemssen, Rainer Beaujean and Lukas Burkhardt.

  • How many employees does Gerresheimer have?

    Gerresheimer has 9,904 employees.

  • Who are Gerresheimer competitors?

    Competitors of Gerresheimer include West Pharmaceutical Services, SCHOTT and Aptar.

  • Where is Gerresheimer headquarters?

    Gerresheimer headquarters is located at Klaus-Bungert-Straße 4, Düsseldorf.

  • Where are Gerresheimer offices?

    Gerresheimer has offices in Düsseldorf, Bünde, Essen, Pfreimd and in 19 other locations.

  • How many offices does Gerresheimer have?

    Gerresheimer has 26 offices.